Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Oral Oncol. 2011 Mar 21;47(5):371–375. doi: 10.1016/j.oraloncology.2011.02.018

Table 2.

Levels of expression of ANGPTL4 or VEGF in oral human KS lesions. Immunohistochemical reactivity was graded in a semiquantitative manner according to the percentage of positive tumor cells (− = 0%; + = <20%; ++ = 20%–50%; +++ = >50%).

Case ANGPTL4 VEGF
1 ++ +
2 + +++
3 ++
4 +++
5 + +++
6 +++ ++
7 +++ ++
8 +++
9 +++ ++
10 ++ +
11
12 + ++
13 ++ +
14 + +
15 +++
16 ++ ++
17 ++
18 +++ +++
19 + ++
20 ++ +++
21 +++ +++
22 +++ +++
23 + ++
24 +++
25 +++ +